⌘K

Login Start Free

Home/Filings/4/0001855763-21-000011

4//SEC Filing

Baxter Nicholas W 4

Accession 0001855763-21-000011

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 11:23 AM ET

Size

8.3 KB

Accession

0001855763-21-000011

Insider Transaction Report

Form 4

Period: 2021-05-07

Lexaria Bioscience Corp.LEXX

Baxter Nicholas W

Director

Transactions

Other
Stock Options
2021-05-07−5,000→ 1,500 total
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (5,000 underlying)

Holdings

Stock Options
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (5,000 underlying)
5,000
Stock Options
Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (1,500 underlying)
6,500
common shares
11,000

Footnotes (1)

[F1]Cancellation of Options

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001312326

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 11:23 AM ET
Size: 8.3 KB

View on SEC.gov